Skip to main content

Famotidine

NDC 0615-8559 · NCS HealthCare of KY, LLC dba Vangard Labs

Generic nameFamotidine
Dosage formTABLET
RouteORAL
Active ingredient(s)FAMOTIDINE
Strength40 mg/1
Pharmacologic classHistamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
Marketing categoryANDA

Packages

0615-8559-05 — 15 TABLET in 1 BLISTER PACK (0615-8559-05)

0615-8559-39 — 30 TABLET in 1 BLISTER PACK (0615-8559-39)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0363-0713 — Famotidine, Calcium Carbonate, Magnesium Hydroxide, 0363-1203 — famotidine, 0363-1899 — Famotidine, 0363-4036 — famotidine, calcium carbonate, magnesium hydroxide, 0363-4400 — Famotidine, 0363-5300 — Famotidine, 0363-9607 — Famotidine, 0527-5190 — Famotidine, 0536-1298 — Famotidine, 0615-8558 — Famotidine, 0641-6021 — Famotidine, 0641-6022 — Famotidine, 0641-6023 — Famotidine, 0832-6045 — Famotidine, 0904-5529 — Famotidine, 0904-5780 — Famotidine, 0904-7193 — Famotidine, 10267-5689 — Famotidine, 10267-5690 — Famotidine, 11673-697 — Famotidine, +401 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels